Physician profile
Gabriel Rodriguez
NPI 1063509347
$4,893.31
in general payments reported to CMS, 2019-2025
30 companies · $901 in 2025
The $901 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $281 · 2021: $479 · 2022: $234 · 2023: $678 · 2024: $1,829 · 2025: $901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,715 · Travel and Lodging: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,714.94 |
| Travel and Lodging | $693.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,586.23 | 2019-2025 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $649.53 | 2019-2023 | Myrbetriq, Xtandi |
| Boston Scientific Corporation | $423.53 | 2019-2024 | Solyx Sis System, Rezum Generator, Greenlight Xps |
| Saluda Medical Americas, INC. | $423.52 | 2024-2025 | Evoke |
| Sumitomo Pharma America, INC. | $222.06 | 2024-2025 | Gemtesa |
| W. L. Gore & Associates, INC. | $217.31 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Coloplast Corp | $184.87 | 2023-2025 | Speedicath |
| Inspire Medical Systems, INC. | $122.94 | 2024 | Inspire |
| Abbvie INC. | $122.04 | 2023-2025 | Botox |
| Convatec INC. | $107.34 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $77.28 | 2019-2020 | |
| Tolmar, INC. | $71.52 | 2023-2025 | Jatenzo, Eligard |
| Laborie Medical Technologies Corp. | $69.05 | 2020-2023 | |
| Forte Bio-Pharma LLC | $68.77 | 2019 | |
| Ambu INC. | $63.80 | 2022-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $52.99 | 2021 | |
| Pfizer INC. | $49.44 | 2024-2025 | |
| Edap Technomed INC | $40.78 | 2022 | |
| Novo Nordisk INC | $39.02 | 2023 | Wegovy |
| 180 Medical, INC. | $38.91 | 2019 | |
| Rochester Medical Corporation | $35.67 | 2022 | |
| Halozyme INC | $35.53 | 2023 | |
| Teleflex LLC | $34.57 | 2024 | |
| Axonics, INC. | $33.45 | 2022-2024 | Axonics |
| Medtronic, INC. | $30.57 | 2024 | Interstim |
| Redhill Biopharma INC. | $21.38 | 2021 | |
| Cook Medical LLC | $21.36 | 2025 | Litho 150 |
| Urovant Sciences INC | $18.93 | 2021 | |
| Antares Pharma, INC. | $17.82 | 2024 | Xyosted |
| Allergan, INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.